Methods for accelerating bone and cartilage growth and repair

Details Methods for accelerating bone and cartilage growth and repair Methods for accelerating bone and cartilage growth and repair

2005-07-12

2005-07-12

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

06916783

ABSTRACT:
The present invention provides improved methods, kits, and compositions for enhancing bone, cartilage and cartilage repair, bone and prosthesis implantation, and attachment and fixation of cartilage and cartilage to bone or other tissues, and chondrocyte proliferation composing the administration of an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2type 2 receptor agonists.

REFERENCES:
patent: 4642120 (1987-02-01), Nevo et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5015629 (1991-05-01), diZerega
patent: 5053050 (1991-10-01), Itay
patent: 5171273 (1992-12-01), Silver et al.
patent: 5324775 (1994-06-01), Rhee et al.
patent: 5443515 (1995-08-01), Cohen et al.
patent: 5464439 (1995-11-01), Gendler
patent: 5607474 (1997-03-01), Athanasiou et al.
patent: 5629292 (1997-05-01), Rodgers et al.
patent: 5656598 (1997-08-01), Dunstan et al.
patent: 5686116 (1997-11-01), Bockman et al.
patent: 5693616 (1997-12-01), Krstenansky et al.
patent: 5700774 (1997-12-01), Hattersley et al.
patent: 5716935 (1998-02-01), Rodgers et al.
patent: 5736372 (1998-04-01), Vacanti et al.
patent: 5834432 (1998-11-01), Rodgers et al.
patent: 5916207 (1999-06-01), Toyoda
patent: 5955430 (1999-09-01), Rodgers et al.
patent: 6248587 (2001-06-01), Rodgers et al.
patent: 6498138 (2002-12-01), Rodgers et al.
patent: WO 88/00205 (1988-01-01), None
patent: WO 95/08337 (1995-03-01), None
patent: WO 95/08565 (1995-03-01), None
patent: WO 96/14858 (1996-05-01), None
patent: WO 96/15795 (1996-05-01), None
patent: WO 96/39164 (1996-12-01), None
patent: WO 96/40090 (1996-12-01), None
patent: WO 98/26795 (1998-06-01), None
patent: WO 98/32457 (1998-07-01), None
patent: WO 98/33813 (1998-08-01), None
patent: WO 99/26644 (1999-06-01), None
patent: WO 99/31125 (1999-06-01), None
patent: WO 99/46285 (1999-09-01), None
Rudikoff et al. Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. 1982 Mar.;79(6):1979-83.
Okazaki, et al., (1996), Ann. Rheum. Dis., 55: pp. 181-186.
Price, et al., (1982), Proc. Natl. Acad. Sci. USA, 79: pp. 7734-7738.
Georgescu, et al., (1988), In Vitro Cell. Dev. Biol., 24: pp. 1015-1022.
Kream, et al., (1985), Endocrinol., 116: pp. 296-302.
Lowry, et al., (1954), J. Biol. Chem., 207: pp. 19-37.
Kato, et al., (1985), J. Cell Biol., 100: pp. 477-485.
Hatton, et al., (1997), J. of Endocrinol., 152: pp. 5-10.
Lamparter, et al., (1998), Physiol., 175: pp. 89-98.
Hiruma, et al., (1997), Biochem and Biophys. Res. Commun., 230: pp. 176-178.
Hagiwara, et al., (1998), J. Of Endocrinology, 156: pp. 543-550.
Speth and Kim, (1990), BBRC, 169: pp. 997-1006.
Catalioto, et al., (1994), Eur. J. Pharmacol., 256: pp. 93-97.
Bryson, et al., (1992), Eur. J. Pharmacol., 225: pp. 119-127.
Janiak, et al., (1992), Hypertension, 20: pp. 737-745.
Prescott, et al., (1991), Am. J. Pathol., 139: 1291-1295.
Kauffman, et al., (1991), Life Sci., 49: pp. 223-228.
Viswanathan, et al., (1992), Peptides, 13: pp. 783-786.
Kimura, et al., (1992), BBRC, 187: pp. 1083-1090.
Pfeilschifter, et al., (1992), Eur. J. Pharmacol., 225: pp. 57-62.
Jaiswal, et al., (1992), Hypertension 19(Suppl. II): II-49-II-55.
Edwards and Stack, (1993), J. Pharmacol. Exper. Ther., 266: pp. 506-510.
Jaiswal, et al., (1993), J. Pharmacol. Exper. Ther., 265: pp. 664-673.
Jaiswal, et al., (1991), Hypertension, 17: pp. 1115-1119.
Portsi, et al., (1994), Br. J. Pharmacol., 111: pp. 652-654.
Regoli, et al., (1974), Pharmacological Reviews, 26: pp. 69-123.
Clouston, et al., (1988), Genomics, 2: pp. 240-248.
Kageyama, et al., (1984), Biochemistry, 23: pp. 3603-3609.
Ohkubo, et al., (1983), Proc. Natl. Acad. Sci., 80: pp. 2196-2200.
Dzau, et al., (1989), J. Mol. Cell. Cardiol., 21: S7 (Supp III).
Berk, et al., (1989), Hypertension, 13: pp. 305-314.
Kawahara, et al., (1988), BBRC, 150P pp. 52-59.
Naftilan, et al., (1989), J. Clin. Invest., 83: pp. 1419-1423.
Taubman, et al., (1989), J. Bio. Chem., 264: 526-530.
Nakahara, et al., (1992), BBRC, 184: pp. 811-818.
Stouffer and Owens, (1992), Circ. Res., 70: p. 820-828.
Wolf, et al., (1992), Am. J. Pathol., 140: pp. 95-107.
Bell and Madri, et al., (1990), Am. J. Pathol., 137: pp. 7-12.
Fernandez, et al., (1985), J. Lab. Clin. Med., 105: p. 141-145.
LeNoble, et al., (1991), Eur. J. Pharmacol, 195: pp. 305-306.
Slovik, et al., (1986), J. Bone & Min. Res., 1: pp. 377-381.
Toriumi, et al., (1991), Arch. Otolaryngol Head Neck Surg., 117: pp. 1101-1112.
Gerhart, et al., (1991), Trans Orthop Res Soc., 16: p. 172.
Wozney, et al., (1993), Bone Morphogenetic Proteins and Their Gene Expression, in Cellular and Molecular Biology of Bone, (Academic Press, Inc.), pp. 131-167.
Wozney, et al., (1988), Science, 242: pp. 1528-1534.
Sporn, et al., (1987), J. Cell. Biol., 105: pp. 1039-1045.
Centrella, et al., (1987), J. Biol. Chem., 262: pp. 2869-2874.
Chenu, et al., (1988), Proc. Natl. Acad. Sci. U.S.A., 85: pp. 5683-5687.
Kiebzak, et al., (1988), J. Bone Min. Res., 3: pp. 439-446.
Joyce, et al., (1990), J. Cell. Biol., 110: pp. 2195-2207.
Noda and Camilliere, (1989), Endocrinology, 124: pp. 2991-2994.
Dijke, et al., Bio/Technology, (1989), 7: pp. 793-798.
Hagiwara, et al., (1998), “Regulation of bone metabolism by vasoactive peptides” Saishin Igaku, vol.:53 (6) pp. 1289-1294 (Translated from Japanese).
Pierre Schelling, et al., (1979), J. Cell. Physiol., “Effects of Angiotensin II and Angiotensin II Antagonist Saralasin on Cell Growth and Renin in 3T3 and SVST3 Cells”, vol.: 98, pp. 503-514.

Affiliated with

Also associated with

Rating

Methods for accelerating bone and cartilage growth and repair does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for accelerating bone and cartilage growth and repair, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for accelerating bone and cartilage growth and repair will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3369819